WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Steven KannerChief Scientific Officer2024-02-0630,577$2.69
$82.25kBuy
Rachel E. HaurwitzPresident and CEO2023-06-0810,000$2.96
$29.60kBuy

1 of 1

CRBU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.83%7,068,468$28.34MInstitution
Pfm Health Sciences LP7.18%6,480,764$25.99MInstitution
Avidity Partners Management LP7.04%6,360,212$25.50MInstitution
State Street Corp5.67%5,119,666$20.53MInstitution
Vanguard Group Inc4.39%3,962,044$15.89MInstitution
Point72 Asset Management LP3.90%3,521,376$14.12MInstitution
Rachel E. Haurwitz3.88%3,508,095$14.07MInsider
Fmr LLC3.68%3,323,284$13.33MInsider
Alkeon Capital Management LLC3.45%3,113,564$12.49MInstitution
Paradigm Biocapital Advisors LP3.24%2,923,851$11.72MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU76.47%8.74%Net BuyingNet Buying
ADPT62.07%37.93%Net SellingNet Selling
TVGN1.50%98.50%Net Selling
AURA74.74%17.47%Net BuyingNet Selling
JSPR60.15%39.85%Net BuyingNet Buying

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 76.47% institutional shareholders, 8.74% Caribou Biosciences insiders, and 14.78% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.51M shares representing 3.88% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $13.72M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.